Trademark: 88817003
Word
SCINTILLA PHARMACEUTICALS
Status
Dead
Status Code
606
Status Date
Monday, July 3, 2023
Serial Number
88817003
Mark Type
3000
Filing Date
Monday, March 2, 2020
Published for Opposition
Tuesday, April 6, 2021
Abandoned Date
Monday, July 3, 2023

Trademark Owner History
Scintilla Pharmaceuticals, Inc. - Owner At Publication

Classifications
44 Providing health information
42 Research and development in the pharmaceutical and biotechnology fields
The mark consists of the words "SCINTILLA PHARMACEUTICALS" preceded by a stylized image of a teardrop.
Color is not claimed as a feature of the mark.
"PHARMACEUTICALS"

Trademark Events
Jul 3, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 3, 2023
Abandonment - No Use Statement Filed
Dec 1, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 29, 2022
Sou Extension 3 Granted
Nov 29, 2022
Sou Extension 3 Filed
Nov 29, 2022
Sou Teas Extension Received
May 6, 2022
Notice Of Approval Of Extension Request E-Mailed
May 4, 2022
Sou Extension 2 Granted
May 4, 2022
Sou Extension 2 Filed
May 4, 2022
Sou Teas Extension Received
Nov 11, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 9, 2021
Sou Extension 1 Granted
Nov 9, 2021
Sou Extension 1 Filed
Nov 9, 2021
Sou Teas Extension Received
Jun 1, 2021
Noa E-Mailed - Sou Required From Applicant
Apr 6, 2021
Official Gazette Publication Confirmation E-Mailed
Apr 6, 2021
Published For Opposition
Mar 17, 2021
Notification Of Notice Of Publication E-Mailed
Mar 4, 2021
Approved For Pub - Principal Register
Feb 25, 2021
Teas/Email Correspondence Entered
Feb 25, 2021
Correspondence Received In Law Office
Feb 22, 2021
Assigned To Lie
Nov 19, 2020
Teas Response To Office Action Received
May 22, 2020
Notification Of Non-Final Action E-Mailed
May 22, 2020
Non-Final Action E-Mailed
May 22, 2020
Non-Final Action Written
May 20, 2020
Assigned To Examiner
Mar 10, 2020
Notice Of Design Search Code E-Mailed
Mar 8, 2020
New Application Office Supplied Data Entered
Mar 5, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24